How strong is the evidence that these drugs are more renoprotective ... controlled trials in which ACE inhibitors or ARBs were compared with other antihypertensive agents or placebo for prevention ...

In addition to their capacity to lower systemic blood pressure, angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-II receptor blockers (ARBs) are thought to have specific ...

The angiotensin receptor blockers (ARBs), which ... that as the dose of a drug is increased, there is declining additional efficacy -- or in the case of an antihypertensive agent, BP-lower-ing ...

There is little evidence that antihypertensive drugs worsen COVID-19, and scientists are instead ... inhibitors and angiotensin receptor blockers (ARBs)—and COVID-19 are scant. Yet media coverage of ...

One large study from Germany showed a hazard ratio of 0.77 (95% CI 0.65-0.90) for epilepsy incidence among ARB users compared with users of other antihypertensive drug classes. An even larger U.S ...

Angiotensin receptor blockers (ARBs) were linked with a lower incidence of new-onset epilepsy in people with hypertension compared with other antihypertensive drugs. (JAMA Neurology) Prolonged ...

Not currently on ACEI/ARB, previously on low doses of ACEI ... consider dose adjustment of diuretics, concomitant antihypertensive drugs, and treatment of other causes of hypotension (eg ...